Smoking, drinking, and depression: comorbidity in head and neck cancer patients undergoing radiotherapy

Abstract We aimed to determine the prevalence and co‐occurrence of tobacco smoking, alcohol consumption, and depressive symptoms among a sample of head and neck cancer (HNC) patients undergoing radiotherapy. A total of 307 HNC patients participated in a multi‐site stepped‐wedge randomized controlled...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristen McCarter, Amanda L. Baker, Benjamin Britton, Luke Wolfenden, Chris Wratten, Judith Bauer, Sean A. Halpin, Gregory Carter, Alison K. Beck, Lucy Leigh, Christopher Oldmeadow
Format: Article
Language:English
Published: Wiley 2018-06-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.1497
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract We aimed to determine the prevalence and co‐occurrence of tobacco smoking, alcohol consumption, and depressive symptoms among a sample of head and neck cancer (HNC) patients undergoing radiotherapy. A total of 307 HNC patients participated in a multi‐site stepped‐wedge randomized controlled trial (RCT) evaluating the effectiveness of a dietitian‐delivered health behavior intervention in patients with HNC undergoing radiotherapy. During week one of radiotherapy patients completed measures of smoking, alcohol consumption, and level of depression. Approximately one‐fifth (21%) of patients had two or more co‐occurring problems: current smoking, hazardous alcohol use, and/or likely presence of a major depressive episode (MDE). Approximately one‐third (34%) of the sample were current smokers, one‐third (31%) were drinking hazardously and almost one‐fifth (19%) had likely cases of depression. Comorbidity of smoking, hazardous alcohol use, and MDE is high in HNC patients, and interventions need to address this cluster of cancer risk factors.
ISSN:2045-7634